Literature DB >> 21874519

The biliopancreatic diversion with a duodenal switch (BPDDS): how is it optimally performed?

Villy Våge1, Ronny Gåsdal, Camilla Laukeland, Nils Sletteskog, Jan Behme, Arnold Berstad, John Roger Andersen.   

Abstract

BACKGROUND: The biliopancreatic diversion with duodenal switch can be performed by different combinations of restriction and malabsorption. The aim of this study was to evaluate weight loss and potential side effects for two variants of the procedure.
METHODS: All patients eligible for a 2-year follow-up (n = 182) was included in the study. Thirty-five patients (group A) had a gastric remnant with a volume of approximately 200 ml, an alimentary limb (AL) of 250 cm, and a common channel (CC) of 100 cm, while 147 patients (group B) had a gastric remnant of 100-120 ml, an AL of 40%, and a CC of 10% of the small bowel length. Preoperative variables, such as body mass index (BMI), sex, age, and factors that might influence weight loss, and postoperative weight loss and side effects were registered and compared.
RESULTS: Preoperatively, the BMI was 50.6 in group A and 52.1 in group B (ns), with no difference in age, sex, or variables that might influence weight loss. At 2 years, the BMI was 33.1 in group A (n = 34) and 28.5 in group B (n = 119) with an adjusted difference in weight loss of 5.6 BMI units between the groups (p < 0.001). Vitamin D status was also better in group B than in group A at follow-up, while there was no difference in side effects.
CONCLUSIONS: Patients with a remnant stomach of 100-120 ml, and AL and CC with individually adapted lengths had a larger weight loss and better vitamin D status postoperatively without an increase in side effects.

Entities:  

Mesh:

Year:  2011        PMID: 21874519     DOI: 10.1007/s11695-011-0496-9

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  21 in total

1.  Body fat content and 25-hydroxyvitamin D levels in healthy women.

Authors:  Sonia Arunabh; Simcha Pollack; James Yeh; John F Aloia
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

2.  Weight loss prior to bariatric surgery is not a pre-requisite of excess weight loss outcomes in obese patients.

Authors:  Guillaume Becouarn; Philippe Topart; Patrick Ritz
Journal:  Obes Surg       Date:  2010-02-20       Impact factor: 4.129

Review 3.  Reporting weight loss 2007.

Authors:  Mervyn Deitel; Khaled Gawdat; John Melissas
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

4.  Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2000

5.  Duodenal switch: an effective therapy for morbid obesity--intermediate results.

Authors:  A Baltasar; R Bou; M Bengochea; F Arlandis; C Escrivá; J Miró; R Martínez; N Pérez
Journal:  Obes Surg       Date:  2001-02       Impact factor: 4.129

6.  Patient characteristics impacting excess weight loss following laparoscopic adjustable gastric banding.

Authors:  Wai Yip Chau; Hans J Schmidt; Wael Kouli; Dan Davis; Annette Wasielewski; Garth H Ballantyne
Journal:  Obes Surg       Date:  2005-03       Impact factor: 4.129

7.  Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study.

Authors:  J Karlsson; C Taft; A Rydén; L Sjöström; M Sullivan
Journal:  Int J Obes (Lond)       Date:  2007-03-13       Impact factor: 5.095

8.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

9.  Depression and anxiety: their predictive function for weight loss in obese individuals.

Authors:  Tanja Legenbauer; Martina De Zwaan; Andrea Benecke; Barbara Muhlhans; Frank Petrak; Stephan Herpertz
Journal:  Obes Facts       Date:  2009-08-17       Impact factor: 3.942

10.  Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients.

Authors:  Villy Våge; Jan Helge Solhaug; Arnold Berstad; Knut Svanes; Asgaut Viste
Journal:  Obes Surg       Date:  2002-06       Impact factor: 4.129

View more
  8 in total

1.  Predictors for remission of major components of the metabolic syndrome after biliopancreatic diversion with duodenal switch (BPDDS).

Authors:  Villy Våge; Roy M Nilsen; Arnold Berstad; Jan Behme; Nils Sletteskog; Ronny Gåsdal; Camilla Laukeland; Gunnar Mellgren
Journal:  Obes Surg       Date:  2013-01       Impact factor: 4.129

2.  Preserve common limb in duodenal-jejunal bypass surgery benefits rats with type 2-like diabetes.

Authors:  Shi-Yun Zhang; Xue-Jun Sun; Jian-Bao Zheng; Wei Wang; Dong Liu; Nan-Zheng Chen; Sai He; Xiong-Wei Huo; Wanli Smith
Journal:  Obes Surg       Date:  2014-03       Impact factor: 4.129

Review 3.  The role of hormonal factors in weight loss and recidivism after bariatric surgery.

Authors:  S D Pedersen
Journal:  Gastroenterol Res Pract       Date:  2013-10-23       Impact factor: 2.260

4.  Inflammatory markers, the tryptophan-kynurenine pathway, and vitamin B status after bariatric surgery.

Authors:  Monika H E Christensen; Dag J Fadnes; Therese H Røst; Eva R Pedersen; John R Andersen; Villy Våge; Arve Ulvik; Øivind Midttun; Per M Ueland; Ottar K Nygård; Gunnar Mellgren
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

Review 5.  Malabsorption as a Therapeutic Approach in Bariatric Surgery.

Authors:  Adrian T Billeter; Lars Fischer; Anna-Laura Wekerle; Jonas Senft; Beat Müller-Stich
Journal:  Viszeralmedizin       Date:  2014-06

6.  Five-year changes in health-related quality of life after biliopancreatic diversion with duodenal switch.

Authors:  Anny Aasprang; John Roger Andersen; Villy Våge; Ronette L Kolotkin; Gerd K Natvig
Journal:  Obes Surg       Date:  2013-10       Impact factor: 4.129

7.  Changes in Serum Fatty Acid Levels During the First Year After Bariatric Surgery.

Authors:  Chenchen Lin; Villy Våge; Svein Are Mjøs; Olav Martin Kvalheim
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

8.  Intensive lifestyle intervention provides rapid reduction of serum fatty acid levels in women with severe obesity without lowering omega-3 to unhealthy levels.

Authors:  C Lin; J R Andersen; V Våge; T Rajalahti; S A Mjøs; O M Kvalheim
Journal:  Clin Obes       Date:  2016-06-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.